| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.4M | -49.5% |
| Cost of Revenue | $15.0M | -51.7% |
| Gross Profit | $446K | +202.3% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $4.0M | -1.6% |
| Operating Income | -$3.8M | +37.5% |
| Pre-tax Income | -$3.4M | +43.6% |
| Income Tax | $399K | — |
| Net Income | -$3.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $812K | -0.6% |
| Accounts Receivable | $1.6M | +91.2% |
| Current Assets | $9.2M | +2.4% |
| Total Assets | $9.7M | -13.8% |
| Current Liabilities | $5.8M | +20.4% |
| Total Liabilities | $6.0M | +19.9% |
| Stockholders' Equity | $3.7M | -41.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.1M | -2.3% |
| Capital Expenditures | $3K | -96.3% |
| Investing Cash Flow | $895K | +158.2% |
| Financing Cash Flow | $1.1M | — |
| Free Cash Flow | -$2.1M | +1.5% |
| +37.0% |
| EPS (Basic) | -$1.86 | -124.1% |